PDCD1 and metastatic melanoma: Over the last decade, anti-programmed cell death 1 (PD1) antibodies (Abs) and ICIs, in combination with or without another drugs such as anti-CTLA-4 Abs, have been widely used for the treatment of advanced and metastatic melanoma (Larkin et al., 2015; Larkin et al., 2019).